PACLITAXEL TAXANE - AN OVERVIEW

In September 2001, Good proposed paclitaxel for the treatment of Highly developed breast cancer after the failure of anthracyclic chemotherapy, but that its initial-line use really should be restricted to medical trials. In September 2006, NICE advisable paclitaxel shouldn't be Utilized in the adjuvant treatment of early node-favourable breast most